The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

With semaglutide patents set to expire in 2026, Indian pharma giants are ramping up peptide production and device tie-ups to ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

KanawatTH Most major stock indexes across the globe ended the week lower over tariff jitters, while the focus also remained ...

Novo Nordisk has reported another significant criticality: the presence of unauthorized versions of its drugs on the US ...

Redditors have complained Ozempic has caused them to lose their libido, resulting in less time spent self-pleasuring.